Health news today and breaking health news with clear reporting on medical research, healthcare policy, hospitals, pharma, mental health, outbreaks and wellness for readers who want speed, precision and substance.
The AI pioneer who built the leading alternative to large language models joins Cellular Intelligence's advisory board alongside Moderna co-founder Bob Langer, as the company's DeltaStem foundation model moves toward clinical application
A New Delhi think tank is pressing India and the EU to treat their landmark free trade agreement as a scaffold for health security, arguing the pact should be judged not by
Saima Wazed, the recently resigned WHO regional director for South-East Asia and daughter of Sheikh Hasina, has broken her year of silence in a FirstPost op-ed, accusing WHO Director-General Tedros of a
Pennsylvania's measles outbreak has reached three deaths and 693 confirmed cases across 38 counties. An unvaccinated Jefferson County woman died September 12, the same week CDC Director Dr. Erica Schwartz confirmed Pennsylvania
Bangladesh has recorded more than 1,000 measles deaths and 187,000 infections since March, the world's worst active outbreak per the CDC. An emergency campaign vaccinated 18 million children but missed four million,
The FDA's September 3 approval of Zanvastro marks the first disease-modifying treatment for Alexander disease, an ultra-rare neurological disorder affecting roughly one in one million people. The drug targets the genetic root
A review of 18 clinical trials found that structured mindfulness programs lower blood pressure by up to 7.6 mmHg and reduce inflammatory markers within weeks. The physiological gains do not persist once
A Novartis oral pill for relapsing multiple sclerosis outperformed standard therapy in two large Phase III trials, and unlike a rival BTK inhibitor the FDA declined over liver concerns, it showed no
Your immune cells keep a molecular record of every year spent with obesity, and that record does not reset when the weight does. New research from the University of Birmingham explains why
The FDA has accepted for review Oxnimbi (AD109), a once-nightly pill for sleep apnea patients who refused CPAP. In a Phase 3 trial of 646 patients, it cut breathing interruptions by 44
Follow